Back
Dianthus Therapeutics 10K Form
Sell
1
DNTH
Dianthus Therapeutics
Last Price:
20.87
Seasonality Move:
12.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DNTH News And Ratings
See the #1 stock for the next 7 days that we like better than DNTH
DNTH Financial Statistics
Sales & Book Value
| Annual Sales: | $2.83M |
|---|---|
| Cash Flow: | $-21.29M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.51 |
| Price / Book: | 2.07 |
Profitability
| EPS (TTM): | -2.50290 |
|---|---|
| Net Income (TTM): | $-67.09M |
| Gross Margin: | -- |
| Return on Equity: | -23.69% |
| Return on Assets: | -22.7% |
Dianthus Therapeutics Earnings Forecast
Key Dianthus Therapeutics Financial Ratios
- The Research & Development expenses have been 1,162.10% of Revenue.
- The Net Earning history of DNTH is -1,541.22% of Total Revenues.
- Per Share Earnings over the last 3 years have been positive in 0 years.
Dianthus Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DNTH |
| Website: | dianthustx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 18.3 |
| Quick Ratio: | 18.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DNTH Technical Analysis vs Fundamental Analysis
Sell
1
Dianthus Therapeutics (DNTH)
is a Sell
Is Dianthus Therapeutics a Buy or a Sell?
-
Dianthus Therapeutics stock is rated a Sell
The current Dianthus Therapeutics [DNTH] share price is $20.77. The Score for DNTH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.